DEN230052 is the FDA 510(k) clearance record for Eversense AP CGM System, a class II device, cleared for Senseonics, Incorporated on under FDA product code SBA (Integrated Continuous Glucose Monitoring System With Sensor Containing Dexamethasone Acetate). FDA's definition for product code SBA reads: "An integrated continuous glucose monitoring system (iCGM) with sensor containing dexamethasone acetate is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time. iCGM systems...". FDA records list 2 510(k) clearances for Senseonics, Incorporated, from to . As of , FDA records show no recalls naming DEN230052.
Clearance record
- Decision date
- Received
- (264 days to decision)
- Product code
- SBA Integrated Continuous Glucose Monitoring System With Sensor Containing Dexamethasone Acetate
- Regulation
- 21 CFR 862.1357
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Applicant
- Senseonics, Incorporated 20451 Seneca Meadows Pkwy., Germantown MD
- Third party review
- No
Clearances, product code SBA
Trailing 12 monthsFDA records hold no clearances under product code SBA in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
